Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Journal of Extracellular Vesicles | CD20+ Extracellular Vesicles Form Immune Complexes with Rituximab to Activate NK Cells
2026-09-03
【Frontier Express】Acta Pharmaceutica Sinica. B | The DSPP/αvß3 Signaling Axis Inhibits Colorectal Cancer Metastasis by Regulating Tumor Vascular Normalization
2026-09-03
【Frontier Express】Acta Pharmaceutica Sinica. B | Application of an HER2-Targeted Pretargeted Theranostic System Combined with a Novel Tetrazine Probe in Tumor-Bearing Mouse Models
2026-09-02
【Frontier Express】Science Translational Medicine | Plasma Proteomics Enhances Cancer-Associated Thrombosis Prediction and Reveals a Targetable IL-17-Driven Endothelial Activation Pathway
2026-09-02
【Frontier Express】Antibodies | Computationally Designed Headless Influenza Hemagglutinin Antigens for Modular Universal Nanoparticle Vaccine Development
2026-09-02
【Frontier Express】Antibodies | Downstream Processing Breakthroughs Drive Monoclonal Antibody Purification and Formulation Development
2026-09-02
【Frontier Express】Cancer Cell | Clonally Expanded Tumor-Infiltrating Plasma Cells after PD-1 Blockade Yield Therapeutic Antibodies Targeting Citrullinated Antigens
2026-09-01






